Comparing Baricitinib vs Tofacitinib
| Baricitinib | Tofacitinib |
|
|---|
| Baricitinib | Tofacitinib |
|
|---|---|---|
|
Prescription only
Prescribed for Alopecia, Rheumatoid Arthritis, COVID-19. Baricitinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Ankylosing Spondylitis, Rheumatoid Arthritis, Ulcerative Colitis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis. Tofacitinib may also be used for purposes not listed... View more |
Related suggestions Rheumatoid Arthritis
|
| More about Baricitinib | More about Tofacitinib | |
| Ratings & Reviews | ||
|
Baricitinib has an average rating of 8.3 out of 10 from a total of 17 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 12% reported a negative effect. |
Tofacitinib has an average rating of 5.7 out of 10 from a total of 175 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 39% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Baricitinib side effects |
View all Tofacitinib side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Olumiant | Xeljanz, Xeljanz Oral Solution, Xeljanz XR | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
12.5 hours |
3 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 516 drugs are known to interact with Baricitinib:
|
A total of 676 drugs are known to interact with Tofacitinib:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
| First Approval Date | ||
|
N/A |
November 06, 2012 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.